Piramal Enterprises board approves scheme for pharma biz demerger

The pharmaceuticals business will get demerged from Piramal Enterprises (PEL) and consolidated in Piramal Pharma, Piramal Enterprises said in a regulatory filing. The amalgamation of PHL Fininvest with PEL will create a listed non-banking financial services entity, it added.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news